Literature DB >> 26461089

Subtyping Pancreatic Cancer.

Andrew V Biankin1, Anirban Maitra2.   

Abstract

The complex tumor microenvironment can make molecularly subtyping cancer using mRNA expression challenging, particularly for cancers with low epithelial content, such as pancreatic cancer. In a recent edition of Nature Genetics, Moffitt and colleagues show that subtracting normal epithelial transcripts can provide insights into the molecular pathology of pancreatic cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2015        PMID： 26461089     DOI： 10.1016/j.ccell.2015.09.020

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  24 in total

1.  BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma.

Authors:  Alex B Blair; Vincent P Groot; Georgios Gemenetzis; Jishu Wei; John L Cameron; Matthew J Weiss; Michael Goggins; Christopher L Wolfgang; Jun Yu; Jin He
Journal:  J Am Coll Surg       Date:  2018-01-05       Impact factor: 6.113

2.  Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.

Authors:  Junya Peng; Bao-Fa Sun; Chuan-Yuan Chen; Jia-Yi Zhou; Yu-Sheng Chen; Hao Chen; Lulu Liu; Dan Huang; Jialin Jiang; Guan-Shen Cui; Ying Yang; Wenze Wang; Dan Guo; Menghua Dai; Junchao Guo; Taiping Zhang; Quan Liao; Yi Liu; Yong-Liang Zhao; Da-Li Han; Yupei Zhao; Yun-Gui Yang; Wenming Wu
Journal:  Cell Res       Date:  2019-07-04       Impact factor: 25.617

3.  Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer.

Authors:  Joseph E Grossman; Lakshmi Muthuswamy; Ling Huang; Dipikaa Akshinthala; Sofia Perea; Raul S Gonzalez; Leo L Tsai; Jonah Cohen; Bruno Bockorny; Andrea J Bullock; Benjamin Schlechter; Mary Linton B Peters; Catherine Conahan; Supraja Narasimhan; Christine Lim; Roger B Davis; Robert Besaw; Mandeep S Sawhney; Douglas Pleskow; Tyler M Berzin; Martin Smith; Tara S Kent; Mark Callery; Senthil K Muthuswamy; Manuel Hidalgo
Journal:  Clin Cancer Res       Date:  2022-02-15       Impact factor: 12.531

Review 4.  New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma.

Authors:  Ritu Raj Singh; Eileen M O'Reilly
Journal:  Drugs       Date:  2020-05       Impact factor: 9.546

5.  A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis.

Authors:  Hong Pan; Huanrong Diao; Wen Zhong; Taifang Wang; Ping Wen; Chunli Wu
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

6.  Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer.

Authors:  Stephan B Dreyer; Rosie Upstill-Goddard; Viola Paulus-Hock; Clara Paris; Eirini-Maria Lampraki; Eloise Dray; Bryan Serrels; Giuseppina Caligiuri; Selma Rebus; Dennis Plenker; Zachary Galluzzo; Holly Brunton; Richard Cunningham; Mathias Tesson; Craig Nourse; Ulla-Maja Bailey; Marc Jones; Kim Moran-Jones; Derek W Wright; Fraser Duthie; Karin Oien; Lisa Evers; Colin J McKay; Grant A McGregor; Aditi Gulati; Rachel Brough; Ilirjana Bajrami; Stephan Pettitt; Michele L Dziubinski; Juliana Candido; Frances Balkwill; Simon T Barry; Robert Grützmann; Lola Rahib; Amber Johns; Marina Pajic; Fieke E M Froeling; Phillip Beer; Elizabeth A Musgrove; Gloria M Petersen; Alan Ashworth; Margaret C Frame; Howard C Crawford; Diane M Simeone; Chris Lord; Debabrata Mukhopadhyay; Christian Pilarsky; David A Tuveson; Susanna L Cooke; Nigel B Jamieson; Jennifer P Morton; Owen J Sansom; Peter J Bailey; Andrew V Biankin; David K Chang
Journal:  Gastroenterology       Date:  2020-10-09       Impact factor: 22.682

Review 7.  Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.

Authors:  Dietrich A Ruess; Kivanc Görgülü; Sonja M Wörmann; Hana Algül
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 4.271

8.  CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.

Authors:  Elisa M Noll; Christian Eisen; Albrecht Stenzinger; Elisa Espinet; Alexander Muckenhuber; Corinna Klein; Vanessa Vogel; Bernd Klaus; Wiebke Nadler; Christoph Rösli; Christian Lutz; Michael Kulke; Jan Engelhardt; Franziska M Zickgraf; Octavio Espinosa; Matthias Schlesner; Xiaoqi Jiang; Annette Kopp-Schneider; Peter Neuhaus; Marcus Bahra; Bruno V Sinn; Roland Eils; Nathalia A Giese; Thilo Hackert; Oliver Strobel; Jens Werner; Markus W Büchler; Wilko Weichert; Andreas Trumpp; Martin R Sprick
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

9.  Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology.

Authors:  James R W Conway; Claire Vennin; Aurélie S Cazet; David Herrmann; Kendelle J Murphy; Sean C Warren; Lena Wullkopf; Alice Boulghourjian; Anaiis Zaratzian; Andrew M Da Silva; Marina Pajic; Jennifer P Morton; Thomas R Cox; Paul Timpson
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

10.  Combined microRNA and mRNA microfluidic TaqMan array cards for the diagnosis of malignancy of multiple types of pancreatico-biliary tumors in fine-needle aspiration material.

Authors:  Thomas M Gress; Ludwig Lausser; Lyn-Rouven Schirra; Hans A Kestler; Malte Buchholz; Lisa Ortmüller; Ramona Diels; Bo Kong; Christoph W Michalski; Thilo Hackert; Oliver Strobel; Nathalia A Giese; Miriam Schenk; Rita T Lawlor; Aldo Scarpa
Journal:  Oncotarget       Date:  2017-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.